BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 27578075)

  • 41. Chronic urticaria in adults: state-of-the-art in the new millennium.
    Criado PR; Criado RF; Maruta CW; Reis VM
    An Bras Dermatol; 2015; 90(1):74-89. PubMed ID: 25672302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current and future therapies for the treatment of histamine-induced angioedema.
    James C; Bernstein JA
    Expert Opin Pharmacother; 2017 Feb; 18(3):253-262. PubMed ID: 28081650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Histaminergic angioedema and chronic urticaria].
    Hacard F; Nosbaum A; Bensaid B; Nicolas JF; Augey F; Goujon C; Bérard F
    Presse Med; 2015 Jan; 44(1):37-42. PubMed ID: 25535159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urticaria and Allergy-Mediated Conditions.
    Jafilan L; James C
    Prim Care; 2015 Dec; 42(4):473-83. PubMed ID: 26612369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of refractory chronic urticaria: current and future therapeutic options.
    Asero R; Tedeschi A; Cugno M
    Am J Clin Dermatol; 2013 Dec; 14(6):481-8. PubMed ID: 24085572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urticaria: A comprehensive review: Treatment of chronic urticaria, special populations, and disease outcomes.
    Antia C; Baquerizo K; Korman A; Alikhan A; Bernstein JA
    J Am Acad Dermatol; 2018 Oct; 79(4):617-633. PubMed ID: 30241624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease.
    Martina E; Diotallevi F; Bianchelli T; Paolinelli M; Offidani A
    Curr Pharm Biotechnol; 2021; 22(1):32-45. PubMed ID: 32603278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute and Chronic Urticaria: Evaluation and Treatment.
    Schaefer P
    Am Fam Physician; 2017 Jun; 95(11):717-724. PubMed ID: 28671445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics.
    Hon KL; Li JTS; Leung AKC; Lee VWY
    Expert Opin Pharmacother; 2021 Mar; 22(4):497-509. PubMed ID: 32990110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluating and managing chronic idiopathic urticaria in adults.
    Webster L; Rider NL; Archambault ME
    JAAPA; 2018 Jul; 31(7):22-26. PubMed ID: 29889715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunomodulating Agents as Antipruritics.
    Erickson S; Nahmias Z; Rosman IS; Kim BS
    Dermatol Clin; 2018 Jul; 36(3):325-334. PubMed ID: 29929604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
    Maurer M; Altrichter S; Bieber T; Biedermann T; Bräutigam M; Seyfried S; Brehler R; Grabbe J; Hunzelmann N; Jakob T; Jung A; Kleine-Tebbe J; Mempel M; Meurer M; Reich K; Ruëff F; Schäkel K; Sengupta K; Sieder C; Simon JC; Wedi B; Zuberbier T; Mahler V; Staubach P
    J Allergy Clin Immunol; 2011 Jul; 128(1):202-209.e5. PubMed ID: 21636116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Omalizumab for chronic urticaria.
    Altman MC; Naimi DR
    N Engl J Med; 2013 Jun; 368(26):2528-30. PubMed ID: 23802532
    [No Abstract]   [Full Text] [Related]  

  • 54. Omalizumab for chronic urticaria.
    Benelli E; Ventura A
    N Engl J Med; 2013 Jun; 368(26):2528. PubMed ID: 23802531
    [No Abstract]   [Full Text] [Related]  

  • 55. Omalizumab for chronic urticaria.
    Wu K; Long H
    N Engl J Med; 2013 Jun; 368(26):2527-8. PubMed ID: 23802530
    [No Abstract]   [Full Text] [Related]  

  • 56. Omalizumab for chronic urticaria.
    Maurer M; Rosén K; Hsieh HJ
    N Engl J Med; 2013 Jun; 368(26):2530. PubMed ID: 23802529
    [No Abstract]   [Full Text] [Related]  

  • 57. The potential role of omalizumab in the treatment of chronic urticaria.
    Stitt JM; Dreskin SC
    Immunotherapy; 2014; 6(6):691-7. PubMed ID: 25186602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal.
    Durack A; Matin RN
    Br J Dermatol; 2014 Jul; 171(1):10-3. PubMed ID: 25066288
    [No Abstract]   [Full Text] [Related]  

  • 59. Effectiveness of as-needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment.
    Türk M; Yılmaz İ; Nazik Bahçecioğlu S; Can P; Ertaş R; Kartal D; Çınar SL; Kocatürk E
    Dermatol Ther; 2021 Jan; 34(1):e14543. PubMed ID: 33190334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Expanding Field of Biologics in the Management of Chronic Urticaria.
    Joshi S; Khan DA
    J Allergy Clin Immunol Pract; 2017; 5(6):1489-1499. PubMed ID: 28734860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.